By Josh White
Date: Tuesday 13 Jan 2026
(Sharecast News) - Shares in Victoria saw director support on Tuesday, after the group disclosed that non-executive director Steve Callaghan purchased 260,000 ordinary shares at 37.93p each on 9 January.
| Director/PDMR Shareholding | 13-Jan-2026 | 15:30 | RNS |
| Holding(s) in Company | 13-Jan-2026 | 12:53 | RNS |
| Holding(s) in Company | 13-Jan-2026 | 12:51 | RNS |
| Results of WSD4000 Early Feasibility Study | 12-Jan-2026 | 07:00 | RNS |
| Three kidneyintelX.dkd Clinical Integrations | 12-Jan-2026 | 07:00 | RNS |
| Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
| Questor : Hikma Pharmaceuticals | 13-Mar-2014 | Telegraph |
| Investment Column:BTG | 06-Oct-2011 | The Independent |
| Investment Column:Genus | 09-Sep-2011 | The Independent |
| Questor :Dechra Pharmaceuticals | 08-Sep-2011 | Telegraph |
| Price | 25,929.61 |
| Closing Price Change | -202.42 |
| % Change | -0.77 % |
| 13-Jan-26 Close | 25,929.61 |
You are here: research